1,200 Shares in Waters Corporation $WAT Acquired by Ransom Advisory Ltd

Key Points

• Ransom Advisory Ltd has acquired a new position in Waters Corporation, purchasing 1,200 shares valued at approximately $442,000.
• Institutional investors and hedge funds now own 94.01% of Waters Corporation's stock, indicating strong institutional confidence in the company.
• Waters reported a year-over-year revenue increase of 8.8% for the last quarter, achieving $771.33 million in revenue, and surpassed EPS expectations with earnings of $2.95 per share.

Ransom Advisory Ltd bought a new position in shares of Waters Corporation (NYSE:WAT - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,200 shares of the medical instruments supplier's stock, valued at approximately $442,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. increased its position in Waters by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 7,272,252 shares of the medical instruments supplier's stock worth $2,680,334,000 after purchasing an additional 173,584 shares in the last quarter. Alliancebernstein L.P. boosted its holdings in Waters by 15.7% in the 1st quarter. Alliancebernstein L.P. now owns 3,070,671 shares of the medical instruments supplier's stock worth $1,131,757,000 after acquiring an additional 416,669 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in Waters by 6.3% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 2,066,482 shares of the medical instruments supplier's stock worth $761,643,000 after acquiring an additional 123,215 shares during the period. Invesco Ltd. boosted its holdings in Waters by 14.0% in the 1st quarter. Invesco Ltd. now owns 1,112,128 shares of the medical instruments supplier's stock worth $409,897,000 after acquiring an additional 136,396 shares during the period. Finally, Northern Trust Corp boosted its holdings in Waters by 2.1% in the 1st quarter. Northern Trust Corp now owns 739,630 shares of the medical instruments supplier's stock worth $272,605,000 after acquiring an additional 15,563 shares during the period. Institutional investors and hedge funds own 94.01% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on WAT. Deutsche Bank Aktiengesellschaft set a $315.00 price target on Waters and gave the stock a "hold" rating in a report on Tuesday, August 5th. Robert W. Baird reduced their target price on Waters from $374.00 to $352.00 and set an "outperform" rating for the company in a research note on Wednesday, July 16th. Scotiabank reiterated a "sector outperform" rating and set a $465.00 target price on shares of Waters in a research note on Friday, July 11th. UBS Group reiterated a "neutral" rating on shares of Waters in a research note on Tuesday, July 15th. Finally, Jefferies Financial Group set a $385.00 price objective on Waters and gave the stock a "buy" rating in a research note on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $378.73.

Waters Price Performance

Shares of NYSE WAT opened at $300.37 on Wednesday. Waters Corporation has a 1-year low of $275.05 and a 1-year high of $423.56. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. The business's fifty day moving average price is $302.86 and its two-hundred day moving average price is $334.78. The firm has a market capitalization of $17.88 billion, a PE ratio of 27.08, a P/E/G ratio of 2.88 and a beta of 1.07.

Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, topping the consensus estimate of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The firm had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. During the same period last year, the company earned $2.63 earnings per share. The firm's revenue for the quarter was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. On average, research analysts expect that Waters Corporation will post 12.86 EPS for the current year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.